Pneumatic Nebulizers Market Report

Pneumatic Nebulizers Market Analysis By Type (Vented, Breath-Actuated), By Region (North America (U.S. & Canada), Europe (UK & Germany), Asia Pacific (Japan, China & India), Latin America (Brazil & Mexico), MEA), And Segment Forecasts, 2014 - 2025

Published: November 2016  |  75 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-194-8

Industry Insights

The global pneumatic nebulizers market was valued at USD 490.6 million in 2015 and is projected to grow at a CAGR of 6.2% over the forecast period. The high growth is attributed to the rising demand for non-invasive methods of drug delivery, increasing incidence of various respiratory disorders, and the surging geriatric population.

The increasing incidence of respiratory diseases is a vital impact rendering factor supporting the growth of this sector. In 2011, according to the American Lung Association, around 10 million Americans suffered from chronic bronchitis. Moreover, the chances of developing chronic bronchitis increases with age as it was determined that out of those 10 million cases around 70.0% people were above 65 years of age.

U.S. pneumatic nebulizers market, by type, 2014 - 2025 (USD Million)

U.S. pneumatic nebulizers market

Nebulizers are electrically powered or battery-operated devices used to administer liquid drug in the form of mist and aerosol. The increased surface area yields a better drug therapeutic effect as compared to inhalation therapy.The device is used to treat various respiratory disorders such
as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis. Moreover, the increasing application of pneumatic nebulizer as a method for treatment of diabetes, migraine, and cancer is expected to drive the demand for pneumatic nebulizers.

Government initiatives and organization funding deployed to improve the current treatment alternatives for respiratory conditions are also expected to result in an upsurge in the demand for inhalation devices.The American Heart Association along with National Association for Stock Car Auto Racing (NASCAR) launched a DRIVE4COPD campaign in 2011. Through this partnership, NASCAR was responsible for screening around three million NASCAR fans for COPD.

Another initiative expected to positively influence the market, is the COPD population screener by the COPD Foundation. Using this screener, Americans citizens who are 35 years and older are screened for COPD through a five-question test. If the screener indicates positive results, the individual is advised to visit a healthcare professional or call the COPD helpline, thereby raising awareness among the population to enable early intervention.

Product Insights

Vented product type held the majority share of the pneumatic nebulizers market in 2015 owing to their better availability and affordability as compared to breath-actuated nebulizers. Moreover, in February 2014, Kitabis Pak was approved by the FDA. This is the first of its kind reusable nebulizer delivering PARI LC PLUS and to bramycin in combination to patients with cystic fibrosis.

Pneumatic nebulizers market, by product, 2015

Pneumatic nebulizers market

However, the sector players are now introducing breath-actuated nebulizers with higher drug delivery capacity and lesser dosage wastage features. Thus, this product type, delivering advanced inhalation therapy is expected to be the fasted growing segment during the forecast period. AeroEclipse II BAN by Monaghan Medical Corporation is an approved breath-actuated nebulizer, with advancement implementing minimal drug wastage, thus encouraging other players in the vertical to launch similar products.

Regional Insights

In 2015, North America accounted for the maximum revenue share. High incidence of COPD and various government initiatives are some of the contributing factors. In 2014, according to the CDC, COPD was established as the third-most important cause of death with 15.7 million people diagnosed with COPD. Moreover, the Ontario government has established two insurance programs called Home Oxygen Program and the Assistive Devices Program to promote higher diagnosis and treatment of COPD. The program covers up to 75% of the equipment cost.

While North America dominates the market, Asia Pacific is expected to be the fastest growing region. Developing economies, such as China and India, are attracting international players to expand their geographic reach. In May 2015, Apex Medical Corporation launched their operations in India spanning across the following product verticals: support surface, respiratory, and autoclaves. The company aims to invest around USD 15 million in the initial development phase.

Competitive Insights

Some of the key players operating in this space include Omron Corporation; Philips; PARI Pharma; GE Healthcare; Allied Healthcare; CareFusion Corporation; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.

Contributors in this sector are developing better technologies to enhanced rug inhalation therapy. In February 2015, PARI Medical received FDA approval for its eRapid powered system. This device delivers Genentech’s Pulmozyme for cystic fibrosis andis designed to expedite the dosage preparation time such that it cuts down the overall treatment time from eight to two minutes.

Moreover, acquisitions undertaken to either expand the product portfolio or to enable market entry into potentially profitable regions are being increasingly witnessed in this sector. In September 2014, Omron Healthcare acquired NS Indústria de Aparelhos Médicos for USD 84 million to expand its nebulizer portfolio and accelerate product sales in Brazil.

Report Scope

Attribute

Details

Base year for market estimation

2015

Actual estimates/Historic market data

2014

Forecast period

2016 - 2025

Market representation

Market revenue in USD Million & CAGR from 2016 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage             

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

 

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the pneumatic nebulizers market on the basis of type and region:

  • Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Breath-actuated

    • Vented

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

        • Canada

      • Europe

        • UK

        • Germany

      • Asia Pacific

        • Japan

        • China

        • India

      • Latin America

        • Brazil

        • Mexico

      • MEA

        • South Africa

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA